Packard to Sell Canberra, Expand Life Science Business | GenomeWeb

NEW YORK, Oct 31 – Packard BioScience said Tuesday it expects to complete the sale of its Canberra Industries subsidiary, a move that would allow the company to expand its life science business.

Mike Zebarth, a spokesman for Packard BioScience, confirmed that the proceeds from the sale would be used to step up the company’s life science efforts, however, he declined to comment on whether that would be done through acquisitions or organic growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.